Home > Boards > US Listed > Biotechs > Adamis Pharmaceuticals Corporation (ADMP)

Just read this post and the shorts are

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
ShortsRClowns Member Profile
 
Followed By 13
Posts 1,787
Boards Moderated 1
Alias Born 06/04/20
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2021 4:07:09 PM
Adamis Announces Results of 2021 Annual Meeting of Stockholders Business Wire - 7/19/2021 4:05:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/13/2021 8:28:19 AM
Adamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th Business Wire - 7/13/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/13/2021 6:04:57 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/13/2021 6:04:07 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 7/1/2021 8:21:18 AM
 Adamis Sends Letter to Stockholders to Address Jerald A. Hammann’s Costly, Distracting and Misguided Campaign Business Wire - 7/1/2021 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/28/2021 7:32:31 AM
Adamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19 Business Wire - 6/28/2021 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2021 10:32:44 AM
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders Business Wire - 6/14/2021 9:00:00 AM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 6/14/2021 6:03:38 AM
Adamis begins clinical trial start-up activities for COVID drug; shares rise 5% Seeking Alpha - 6/11/2021 8:33:04 AM
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 GlobeNewswire Inc. - 6/11/2021 7:30:00 AM
Adamis Pharma soars 18% after FDA accepts Zimhi application for review Seeking Alpha - 6/9/2021 7:46:12 AM
Adamis Provides Update on ZIMHI™ GlobeNewswire Inc. - 6/9/2021 7:30:00 AM
Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19 GlobeNewswire Inc. - 6/7/2021 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/2/2021 5:37:32 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 6/2/2021 8:20:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2021 4:37:06 PM
Adamis Pharmaceuticals Provides Business Update GlobeNewswire Inc. - 6/1/2021 7:30:00 AM
Adamis pharmaceuticals gets deficiency letter from NASDAQ Seeking Alpha - 5/28/2021 4:09:47 PM
Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ GlobeNewswire Inc. - 5/28/2021 4:04:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2021 5:12:17 PM
ShortsRClowns   Wednesday, 05/05/21 10:11:01 AM
Re: Rollgard1 post# 2471
Post # of 3019 
Just read this post and the shorts are crushing ADMP today, currently at .83. I guess even though ADMP is '10 days away from ER and CC' the shorts don't care.

Congrats to all those that locked in profits yesterday and maybe even bought back in this morning. Well done!

.25 isn't a lot of money and 7's aren't lucky. Ignore the noise!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences